Literature DB >> 22729116

Hepatitis B virus genotypes and subgenotypes in the Eastern Black Sea region of Turkey.

Nese Kaklikkaya1, Metin Sancaktar, Rahmet Guner, Celal K Buruk, Iftihar Koksal, Ilknur Tosun, Faruk Aydin.   

Abstract

OBJECTIVE: To determine the hepatitis B virus (HBV) genotypes and subgenotypes in patients with HBV infection in the Eastern Black Sea region of Turkey.
METHODS: One hundred and thirty-seven patients' samples collected over 5 years (January 2005 to January 2010) at Farabi Hospital in Karadeniz Technical University, Trabzon, Turkey were included in the study. All patients were positive for hepatitis B surface antigen (HBsAg) and HBV DNA. The HBV genotypes were determined by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method using an amplified segment of the pre-S region of HBV.
RESULTS: One hundred and twenty-five of the 137 HBV samples (91.3%) were identified as genotype D using the PCR-RFLP method. Twelve isolates had undefined patterns, 122 of the 125 samples (97.6%) were determined as subgenotype D2, 2 (1.6%) were subgenotype D1, and one (0.8%) was subgenotype D-del.
CONCLUSION: Similar findings in the other parts of the Turkey, the predominant patterns of HBV prevailing among patients in the Eastern Black Sea region of Turkey were of genotype D and subgenotype D2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22729116

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  3 in total

1.  HBV Subgenotypes D1, D2, D-del! Are 'Old' Genotyping Methods Interpreted Correctly?

Authors:  Samad Amini-Bavil-Olyaee; Frank Tacke; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2013-07-01       Impact factor: 0.660

2.  Evaluation of PCR-RFLP in the Pre-S Region as Molecular Method for Hepatitis B Virus Genotyping.

Authors:  Rim Ouneissa; Olfa Bahri; Ahlem Ben Yahia; Henda Touzi; Mohamed Msaddak Azouz; Nabyl Ben Mami; Henda Triki
Journal:  Hepat Mon       Date:  2013-10-15       Impact factor: 0.660

3.  Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.

Authors:  Mingjuan Tan; Ajeet S Bhadoria; Fuqiang Cui; Alex Tan; Judith Van Holten; Philippa Easterbrook; Nathan Ford; Qin Han; Ying Lu; Marc Bulterys; Yvan Hutin
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.